ENDRA Life Sciences
NDRA
7 hedge funds and large institutions have $1.09M invested in ENDRA Life Sciences in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
17% more funds holding
Funds holding: 6 → 7 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
41% less capital invested
Capital invested by funds: $1.87M → $1.09M (-$773K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$53K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$106K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$28K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IAM
1
ICM Asset Management
Spokane,
Washington
| $729K | – | – | – |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $137K | -$106K | -2 | -33% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $66K | – | – | – |
|
4
Creative Planning
Overland Park,
Kansas
| $48K | – | – | – |
|
|
VF
5
Virtu Financial
New York
| $30K | +$53K | +1 | New |
|
|
BRWA
6
B. Riley Wealth Advisors
Boca Raton,
Florida
| $25K | – | – | – |
|
|
WEC
7
Winslow Evans & Crocker
Boston,
Massachusetts
| $22K | – | – | – |
|
8
Northern Trust
Chicago,
Illinois
| $17K | – | – | – |
|
9
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $13K | – | – | – |
|
10
Royal Bank of Canada
Toronto,
Ontario, Canada
| $3K | – | – | – |
|
11
Morgan Stanley
New York
| $2K | – | – | – |
|
12
Victory Capital Management
San Antonio,
Texas
| $1K | – | – | – |
|
|
13
Fidelity Investments
Boston,
Massachusetts
| – | -$28K | – | – |
|
NDRA Hedge Fund Activity: Q3 2019 in Review
7 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q3 2019, worth a combined $1.09M — down 41% from $1.87M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new NDRA positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $53K. The largest seller was Vanguard Group, cutting an estimated $106K.
- 7 institutional investors held ENDRA Life Sciences (NDRA) as of Q3 2019, up from 6 in Q2 2019.
- Funds reported $1.09M of ENDRA Life Sciences stock for Q3 2019, down 41% quarter-over-quarter.
- 1 fund opened new ENDRA Life Sciences positions in Q3 2019 and 0 closed out, a net change of +1 holder.
- The largest ENDRA Life Sciences buyer in Q3 2019 was Virtu Financial, an estimated $53K added.
- The largest ENDRA Life Sciences seller in Q3 2019 was Vanguard Group, an estimated $106K sold.
Based on aggregated 13F filings for Q3 2019.